Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
The Journal of pharmacology and experimental therapeutics • 1987 | View Paper
“4 Short infusions of acetylsalicylic acid at low concentrations (2.9 μg/ml), dipyridamole (0.6 μg/ml) and sulphinpyrazone (28.7 μg/ml) selectively inhibited the vasoconstrictor phase of the response to AA.”
“In contrast, bronchoconstriction and thrombocytopenia in vivo, as well as platelet aggregation and the release reaction ex vivo and in vitro, induced by arachidonic acid (AA), were suppressed by sulphinpyrazone.”
European journal of pharmacology • 1982 | View Paper
“Similar findings have been presented by Butler et a1 (1979) who found the inhibitory effect on arachidonic acid-induced platelet aggregation in guinea-pigs was greater 7 h than 1 h after oral administration of sulphinpyrazone.”
The Journal of pharmacy and pharmacology • 1980 | View Paper
“Both sulfinpyrazone and ibuprofen caused a dose-related reduction in flow increment after arachidonic acid.”
“ Sulfinpyrazone , ≥10 mg/kg, and ibuprofen, ≥1 mg/kg, produced a mean reduction of least 60% (p < 0.02 for each) in the vasodilator response to 1 mg arachidonic acid.”